David A Siegel1,2, Jun Li2, Helen Ding3, Simple D Singh2, Jessica B King2, Lori A Pollack2. 1. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. DB Consulting Group, Inc., Atlanta, Georgia.
Abstract
BACKGROUND: Brain and central nervous system (CNS) cancer is the leading cause of cancer death among children and adolescents in the United States. Data from earlier studies suggested racial and ethnic differences in survival among pediatric patients with brain tumor. This study examined racial/ethnic difference in survival using national data and considered the effects of demographic and clinical factors. METHODS: Using National Program of Cancer Registries data, 1-, 3-, and 5-year relative survival (cancer survival in the absence of other causes of death) was calculated for patients with brain and CNS cancer aged < 20 years diagnosed during 2001-2008 and followed up through 2013. Racial and ethnic differences in survival were measured by sex, age, economic status, stage, anatomic location, and histology. Adjusted racial and ethnic difference in 5-year cancer specific survival was estimated using multivariable Cox regression analysis. RESULTS: Using data from 11 302 patients, 5-year relative survival was 77.6% for non-Hispanic white patients, 69.8% for non-Hispanic black patients, and 72.9% for Hispanic patients. Differences in relative survival by race/ethnicity existed within all demographic groups. Based on multivariable analysis, non-Hispanic black patients had a higher risk of death at 5 years after diagnosis compared to non-Hispanic white patients (adjusted hazard ratio = 1.2, 95% confidence interval, 1.1-1.4). CONCLUSIONS: Pediatric brain and CNS cancer survival differed by race/ethnicity, with non-Hispanic black patients having a higher risk of death than non-Hispanic white patients. Future investigation of access to care, social and economic barriers, and host genetic factors might identify reasons for disparities in survival. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: Brain and central nervous system (CNS) cancer is the leading cause of cancer death among children and adolescents in the United States. Data from earlier studies suggested racial and ethnic differences in survival among pediatric patients with brain tumor. This study examined racial/ethnic difference in survival using national data and considered the effects of demographic and clinical factors. METHODS: Using National Program of Cancer Registries data, 1-, 3-, and 5-year relative survival (cancer survival in the absence of other causes of death) was calculated for patients with brain and CNS cancer aged < 20 years diagnosed during 2001-2008 and followed up through 2013. Racial and ethnic differences in survival were measured by sex, age, economic status, stage, anatomic location, and histology. Adjusted racial and ethnic difference in 5-year cancer specific survival was estimated using multivariable Cox regression analysis. RESULTS: Using data from 11 302 patients, 5-year relative survival was 77.6% for non-Hispanic white patients, 69.8% for non-Hispanic black patients, and 72.9% for Hispanic patients. Differences in relative survival by race/ethnicity existed within all demographic groups. Based on multivariable analysis, non-Hispanic black patients had a higher risk of death at 5 years after diagnosis compared to non-Hispanic white patients (adjusted hazard ratio = 1.2, 95% confidence interval, 1.1-1.4). CONCLUSIONS: Pediatric brain and CNS cancer survival differed by race/ethnicity, with non-Hispanic black patients having a higher risk of death than non-Hispanic white patients. Future investigation of access to care, social and economic barriers, and host genetic factors might identify reasons for disparities in survival. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Rebecca D Kehm; Logan G Spector; Jenny N Poynter; David M Vock; Sean F Altekruse; Theresa L Osypuk Journal: Cancer Date: 2018-08-20 Impact factor: 6.860
Authors: Hannah K Weir; Christopher J Johnson; Angela B Mariotto; Donna Turner; Reda J Wilson; Diane Nishri; Kevin C Ward Journal: J Natl Cancer Inst Monogr Date: 2014-11
Authors: Debraj Mukherjee; Thomas Kosztowski; Hasan A Zaidi; George Jallo; Benjamin S Carson; David C Chang; Alfredo Quiñones-Hinojosa Journal: Pediatrics Date: 2009-09-28 Impact factor: 7.124
Authors: Mary T Austin; Emma Hamilton; Denna Zebda; Hoang Nguyen; Jan M Eberth; Yuchia Chang; Linda S Elting; David I Sandberg Journal: J Neurosurg Pediatr Date: 2016-08-19 Impact factor: 2.375
Authors: Meng Liu; Jigisha P Thakkar; Catherine R Garcia; Therese A Dolecek; Lars M Wagner; Emily Van Meter Dressler; John L Villano Journal: Cancer Med Date: 2018-03-13 Impact factor: 4.452
Authors: Vidya Puthenpura; Maureen E Canavan; Jenny N Poynter; Michael Roth; Farzana D Pashankar; Beth A Jones; Asher M Marks Journal: Pediatr Blood Cancer Date: 2021-03-11 Impact factor: 3.167
Authors: David A Siegel; Lisa C Richardson; S Jane Henley; Reda J Wilson; Nicole F Dowling; Hannah K Weir; Eric W Tai; Natasha Buchanan Lunsford Journal: Cancer Date: 2020-07-29 Impact factor: 6.921
Authors: Maral Adel Fahmideh; Erin C Peckham-Gregory; Jeremy M Schraw; Murali Chintagumpala; Stephen C Mack; Philip J Lupo; Michael E Scheurer Journal: Sci Rep Date: 2021-05-17 Impact factor: 4.379